# THC Therapeutics, Inc.

THC Therapeutics, Inc. is a company headquartered in Las Vegas, NV, United States.

## Company overview

- **Legal name:** THC Therapeutics, Inc.
- **Former names in filing history:** HARMONIC ENERGY, INC. (2010-07-28 to 2014-10-29); Aviation Surveillance Systems, Inc. (2009-05-15 to 2010-07-26); Fairytale Ventures Inc (2007-06-22 to 2009-03-10)
- **Classification:** Company
- **Industry (SIC):** 3523 — Farm Machinery & Equipment
- **Headquarters:** Las Vegas, NV, United States
- **Fiscal year end:** July 31
- **SEC CIK:** 0001404935

## About

THC Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001404935, and its reported industry is Farm Machinery & Equipment. In 10-K filed on 2026-02-27, it reported annual revenue of USD 0; net income of USD -811,562; total assets of USD 10,648 for the fiscal period ended 2024-07-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-07-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$811,562 (USD -811,562)
- **Total assets:** $10,648 (USD 10,648)
- **Cash and equivalents:** $35 (USD 35)
- **Operating cash flow:** -$183,273 (USD -183,273)

### FY2023 (period ended 2023-07-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$387,036 (USD -387,036)
- **Total assets:** $12,990 (USD 12,990)
- **Operating cash flow:** -$85,432 (USD -85,432)

### FY2022 (period ended 2022-07-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.5M (USD -1,518,929)
- **Total assets:** $206,901 (USD 206,901)
- **Cash and equivalents:** $32 (USD 32)
- **Operating cash flow:** -$418,917 (USD -418,917)

### FY2021 (period ended 2021-07-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.9M (USD -1,885,445)
- **Total assets:** $480,068 (USD 480,068)
- **Cash and equivalents:** $296,130 (USD 296,130)
- **Operating cash flow:** -$388,477 (USD -388,477)

## Recent SEC filings

- Form 10-K — filed 2026-02-27 — period 2024-07-31 — FORM 10-K
- Form 8-K — filed 2025-07-17 — period 2025-06-07 — FORM 8-K
- Form 8-K — filed 2025-06-27 — period 2025-06-20 — FORM 8-K
- Form 8-K — filed 2025-04-09 — period 2025-04-02 — FORM 8-K
- Form 10-Q — filed 2024-11-13 — period 2024-04-30 — FORM 10-Q
- Form 10-Q — filed 2024-09-05 — period 2024-01-31 — FORM 10-Q
- Form 10-Q — filed 2024-08-09 — period 2023-10-31 — FORM 10-Q
- Form 8-K — filed 2024-03-14 — period 2024-03-08 — FORM 8-K
- Form 10-K — filed 2024-02-26 — period 2023-07-31 — FORM 10-K
- Form 10-Q — filed 2024-01-09 — period 2023-04-30 — FORM 10-Q
- Form 10-Q — filed 2024-01-08 — period 2023-01-31 — FORM 10-Q
- Form 8-K — filed 2023-10-06 — period 2023-09-29 — FORM 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/thc-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology